Mycophenolic acid (sodium)

Mycophenolic acid sodium is a potent uncompetitive inosine monophosphate dehydrogenase (IMPDH) inhibitor with an EC50 of 0.24 μM. Mycophenolic acid sodium demonstrates antiviral effects against a wide range of RNA viruses including influenza. Mycophenolic acid sodium is an immunosuppressive agent. Antiangiogenic and antitumor effects[1][2].

Product Specifications

CAS Number

[37415-62-6]

Product Name Alternative

Mycophenolate (sodium)

UNSPSC

12352005

Hazard Statement

H302, H341, H360, H372, H410

Target

Antibiotic; Apoptosis; Bacterial; Dengue Virus; Endogenous Metabolite; Flavivirus; Fungal

Type

Reference compound

Related Pathways

Anti-infection; Apoptosis; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Cancer; Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/mycophenolic-acid-sodium.html

Purity

99.98

Solubility

DMSO : 175 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(O[Na])CC/C(C)=C/CC1=C(O)C2=C(COC2=O)C(C)=C1OC

Molecular Formula

C17H19NaO6

Molecular Weight

342.32

Precautions

H302, H341, H360, H372, H410

References & Citations

[1]Stephen R Welch, et al. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform. Viruses. 2021 Jun 28;13 (7) :1255.|[2]Sophie Domhan, et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther. 2008 Jun;7 (6) :1656-68.